Dr. Claudia Ulbrich
InvestorVenture Partner at BioMedPartners
Düsseldorf, North Rhine-Westphalia, Germany
Find your path to Dr. Claudia Ulbrich
28 people in our graph share verified history with Dr. Claudia Ulbrich — schools, employers, funds. One of them is your warm intro.
Stefan FäsunlockedDr. Claudia Ulbrich: together at BioMedPartners
×11Dr. Claudia Ulbrich: together at BioMedPartners
About
A serial biotech entrepreneur and senior executive with over 25 years building private and public life sciences companies. She co-founded and built Cardior Pharmaceuticals into an international Phase 2 organization acquired by Novo Nordisk for €1.025 billion in 2024, and previously founded LipoNova AG which IPO'd in 2006.
Experience
Skills & more
- Die Wissenschaft des Wohlbefindens — Yale University
From Dr.'s professional profile.
Colleagues at BioMedPartners
Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. David Urech
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners
Dr. Markus Hosang
Managing Partner at BioMedPartners
Dr. Mattias Ivarsson
Entrepreneur in Residence at BioMedPartners
Frequently asked questions
- Who is Dr. Claudia Ulbrich?
- A serial biotech entrepreneur and senior executive with over 25 years building private and public life sciences companies. She co-founded and built Cardior Pharmaceuticals into an international Phase 2 organization acquired by Novo Nordisk for €1.025 billion in 2024, and previously founded LipoNova AG which IPO'd in 2006.
- Where does Dr. Claudia Ulbrich work?
- Dr. Claudia Ulbrich is Venture Partner at BioMedPartners.
